C4 Therapeutics, Inc.CCCCNASDAQ
LOADING
|||
EBITDA Over Time
Trending higher, below historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-103.37M
↓ 35% below average
Average (6y)
$-76.52M
Historical baseline
Range
High:$-15.12M
Low:$-124.28M
CAGR
+37.8%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-103.37M | +15.3% |
| 2023 | $-122.10M | +1.8% |
| 2022 | $-124.28M | -54.9% |
| 2021 | $-80.25M | -36.4% |
| 2020 | $-58.83M | -85.6% |
| 2019 | $-31.70M | -109.7% |
| 2018 | $-15.12M | - |